In feed-mill processing for nursery piglet medicated premix, Rhei Radix et Rhizoma Powder Veterinary Grade API is milled through a pin mill fitted with a 0.6 mm screen until 90% of particles pass 180 µm, then pre-blended at a 1:5 ratio with rice husk carrier and 1.0% colloidal silicon dioxide before addition to a 500 L horizontal ribbon mixer. The API is incorporated at 0.20–0.50% w/w of complete feed, equivalent to 2.0–5.0 kg per 1,000 kg finished feed; this range is adjusted to maintain total hydroxyanthracene derivatives calculated as rhein within the finished premix specification derived from Ph. Eur. 0291 marker limits. Blend homogeneity is tested at six sampling points after 12 min at 25 rpm, with a coefficient of variation for rhein content not exceeding 5.0%. Loss-on-drying is maintained below 5.0% and water activity below 0.60 to limit hydrolysis of anthraquinone glycosides during storage. Equipment cleanout uses a 2.0% sodium bicarbonate wash followed by ethanol rinse to prevent anthraquinone carryover into non-medicated feed lines. The downstream process concludes with filling into 25 kg multi-wall paper bags with inner PE liners and heat-sealed closures, followed by metal detection at 1.5 mm ferrous and 2.0 mm non-ferrous thresholds. Terminal finished product types are medicated feed premix and oral top-dress powder for post-weaning enteric support. Regulatory compliance during feed mill incorporation is anchored to Regulation (EU) 2019/4 for medicated feed manufacture, VICH GL18 for residual solvent control, VICH GL11 for degradation impurity limits, and Ph. Eur. 2.4.8 for heavy metal screening. In markets where the powder is registered as a zootechnical feed additive rather than a veterinary medicinal product, Regulation (EC) No 1831/2003 authorisation data must be supplied; otherwise the premix falls under veterinary prescription channels.

Which Extraction Sequence Preserves Anthraquinone Solubility in Veterinary Parenteral Solutions?

Injectable use of Rhei Radix et Rhizoma Powder Veterinary Grade API cannot rely on direct reconstitution because tannins and pectic polysaccharides precipitate in aqueous media. The API is therefore subjected to a two-stage hot water extraction at 90–100°C for 2 h in a 500 L jacketed extractor with variable-speed agitation at 30 rpm, followed by alcohol precipitation at 60–70% ethanol to separate high-molecular-weight polysaccharides. The clarified liquor is concentrated to 1.10–1.15 g/cm³ density and treated with 0.5–1.0% w/v activated carbon at 60°C for 30 min. The formulation addition ratio in the final solution is 0.5–2.0 mg/mL total anthraquinones calculated as rhein, corresponding to a crude drug equivalent of 10–20 g API per 100 mL finished injection. The solution is adjusted to pH 6.8–7.4 with disodium hydrogen phosphate and passed through a 0.45 µm polypropylene pre-filter and then a 0.22 µm PVDF sterilising filter into Type II glass vials under nitrogen blanketing. Terminal finished product types are 10 mL and 20 mL sterile injectable solutions for veterinary parenteral administration. Compliance is governed by Regulation (EU) 2019/6 for veterinary medicinal products, Ph. Eur. 2.6.1 for sterility, Ph. Eur. 2.6.14 for bacterial endotoxins with a release limit of 0.5 EU/mg, VICH GL18 for residual ethanol unless ethanol is controlled below 0.5%, and VICH GL11 for degradation products arising from emodin and sennoside oxidation. The process boundary is critical: pH values above 8.0 accelerate oxidation of anthraquinone aglycones and cause colour shifts, while pH below 6.0 reduces rhein solubility and can form filter-blocking agglomerates.

Granule Flow and Sennoside Uniformity in Equine Oral Dosage Forms

Equine oral granules containing Rhei Radix et Rhizoma Powder Veterinary Grade API are produced by high-shear wet granulation: API at 15–25% w/w is pre-blended with lactose monohydrate and microcrystalline cellulose PH101 for 5 min in a 65 L high-shear mixer, then granulated with a 5.0% w/v povidone K30 solution. Wet mass is passed through a 1.25 mm sieve and dried in a fluid-bed dryer at 55°C inlet air with 0.5 m/s air velocity until product temperature reaches 45°C and moisture is ≤4.0%. Dried granules are screened through 1,000 µm and the fraction below 150 µm is limited to ≤15% to maintain flow. The addition ratio is calibrated so that a 5 g single-dose sachet delivers a defined sennoside load consistent with the pharmacopoeial hydroxyanthracene marker. Flow measurements on production batches show Carr index values of 18–24 and Hausner ratios of 1.20–1.30, but published data for this specific equine granulation configuration is limited; these values are in-process control targets rather than regulatory release criteria. Terminal finished product types are 5 g and 10 g laminated foil oral granule sachets for foals and adult horses. Compliance testing follows Ph. Eur. 2.9.5 for mass uniformity, Ph. Eur. 2.9.3 for dissolution of the sennoside fraction in 900 mL phosphate buffer pH 6.8 at 37°C using apparatus II at 50 rpm, VICH GL11 for impurity profiling, Ph. Eur. 2.4.8 for heavy metals, and Ph. Eur. 5.1.8 for microbiological quality. Granulation must avoid temperatures above 60°C because sennoside A and B undergo thermal hydrolysis to rhein anthrone, which alters purge intensity and batch-to-batch colour.

A roller-compacted granulation for 250 mg and 500 mg hard gelatin capsules addressing canine functional constipation incorporates Rhei Radix et Rhizoma Powder Veterinary Grade API at 35–50% w/w with microcrystalline cellulose and pregelatinised starch as dry binders. The powder blend is compacted at 30–50 kN roll pressure on a roller compactor and milled through a 0.8 mm screen to produce granules with a particle size distribution of 0.8–1.4 mm and moisture ≤6.0%. Magnesium stearate is added at 0.5% w/w for 3 min in a diffusion mixer, then the granulation is filled into hard gelatin capsules at 15,000 capsules per hour with in-process weight variation controlled to ±5%. The terminal products are 250 mg and 500 mg hard gelatin capsules in PVC/aluminium blisters; the capsule shell is selected for low aldehyde content to avoid cross-linking with anthraquinone degradation products. Compliance testing includes Ph. Eur. 2.9.5 for uniformity of mass, Ph. Eur. 2.9.3 for dissolution in 0.1 N hydrochloric acid for 60 min, Ph. Eur. 2.4.14 for sulfated ash, and Ph. Eur. 2.4.8 for heavy metal screening. In the United States, compounding and dispensing for companion animals falls under state pharmacy board oversight and 21 CFR 530 for extralabel use, but the herbal powder is not a listed new animal drug under FDA-CVM files; therefore veterinary prescription and client consent records are required. The operational boundary is that long-term daily administration in cats is not recommended because feline metabolism of hydroxyanthracene derivatives is not well characterised and published data for this specific configuration is limited.

When High-Shear Spray Drying Converts Rhei Decoction to a Rehydratable Poultry Powder

For poultry drinking-water applications, Rhei Radix et Rhizoma Powder Veterinary Grade API is subjected to hot water extraction at 95–100°C, followed by vacuum concentration to 1.15–1.20 g/cm³ density before spray drying. The addition ratio in the finished soluble powder is 10–20% native API extract on dry matter, with maltodextrin DE 10–15 as carrier at 20–30% w/w; the drinking-water reconstitution rate is 0.1–0.3 g/L, adjusted to provide a controlled daily anthraquinone intake per bird. Spray drying is conducted with inlet air at 160–170°C, outlet air at 80–85°C, and rotary atomisation at 12,000 rpm; the resulting powder is sieved through 150 µm and must rehydrate in water at 25°C within 120 s without foaming. Terminal finished product types are 100 g and 1 kg polypropylene jars of water-soluble oral powder for broilers, layers, and waterfowl. Compliance for solvent-free extraction is supported by VICH GL18 residual solvent assessment, VICH GL11 impurity profiling, Ph. Eur. 2.4.14 for sulfated ash, and Ph. Eur. 2.4.8 for heavy metals. Because the powder is administered via drinking water to food-producing species, the absence of an established maximum residue limit under Commission Regulation (EU) No 37/2010 means that administration must occur only under veterinary prescription with a provisional withdrawal period assigned through the prescribing veterinarian; otherwise the product is restricted to non-food-producing poultry. The process boundary is that reconstituted solutions are stable only within pH 6.5–7.5; acidic drinking lines below pH 6.0 will precipitate rhein and reduce palatability.

Bolus Erosion Kinetics in Rumen Fluid Simulate Delayed Sennoside Exposure

Ruminant bolus formulations using Rhei Radix et Rhizoma Powder Veterinary Grade API are produced by dry granulation of the API at 25–40% w/w with calcium sulfate dihydrate and microcrystalline cellulose, followed by compression on a 16-station rotary tablet press at 18–25 kN to a core hardness of 80–120 N. The compressed core is coated in a perforated pan coater with a hydrogenated castor oil and ethylcellulose 10% w/w solution in acetone-isopropanol to a thickness of 0.8–1.2 mm, producing 5 g and 10 g rumen-retentive boluses. Release is tested in phosphate buffer pH 6.4 at 39°C using apparatus II at 50 rpm; the coating erodes rather than disintegrates, with sennoside release sustained over 8–12 h. The addition ratio is selected to deliver a controlled rhein-equivalent dose per adult ruminant, and batch-to-batch release endpoints are measured by Ph. Eur. 2.2.29 liquid chromatography against a sennoside B reference. Terminal finished product types are 5 g and 10 g oral boluses for cattle and buffalo enteric support. Compliance testing includes Ph. Eur. 2.9.5 for mass uniformity, Ph. Eur. 2.4.14 for sulfated ash, Ph. Eur. 2.4.8 for heavy metals, and VICH GL11 for degradation impurities. The operational boundary is that Ph. Eur. 2.9.1 disintegration is not applicable to rumen boluses intended for erosion-controlled release; a premature disintegration failure in the abomasum would deliver a high anthraquinone load, so coating integrity is verified by immersion in 0.1 N hydrochloric acid for 2 h with no cracking or swelling beyond 10% thickness increase.